Mesoblast Plans Small Trial After Second CRL For GVHD Cell Therapy

FDA Complete response stamp holder
Mesoblast is planning new trial after second FDA complete response • Source: Nielsen Hobbs; the Pink Sheet | Alamy image

More from Complete Response Letters

More from Product Reviews